parent_name,parent_smiles,metabolite_name,metabolite_smiles,generation,doi
Apixaban,COc1ccc(-n2nc(C(N)=O)c3c2C(=O)N(c2ccc(N4CCCCC4=O)cc2)CC3)cc1,M2,NC(=O)c1nn(-c2ccc(O)cc2)c2c1CCN(c1ccc(N3CCCCC3=O)cc1)C2=O,1,10.1124/dmd.108.025981 10.1124/dmd.108.023143
Lenalidomide,Nc1cccc2c1CN(C1CCC(=O)NC1=O)C2=O,5-hydroxy-lenalidomide,Nc1c(O)ccc2c1CN(C1CCC(=O)NC1=O)C2=O,1,10.1007/s00280-011-1760-3 
Lenalidomide,Nc1cccc2c1CN(C1CCC(=O)NC1=O)C2=O,N-acetyl-lenalidomide,CC(=O)Nc1cccc2c1CN(C1CCC(=O)NC1=O)C2=O,1,10.1007/s00280-011-1760-3 
Rivaroxaban,O=C(NC[C@H]1CN(c2ccc(N3CCOCC3=O)cc2)C(=O)O1)c1ccc(Cl)s1,M-2,O=C(NC[C@H]1CN(c2ccc(N3CCOC(O)C3=O)cc2)C(=O)O1)c1ccc(Cl)s1,1,10.1124/dmd.108.025569 10.1124/dmd.108.025551
Rivaroxaban,O=C(NC[C@H]1CN(c2ccc(N3CCOCC3=O)cc2)C(=O)O1)c1ccc(Cl)s1,M-5,O=C(NC[C@H]1CN(c2ccc(N(CCO)C(=O)CO)cc2)C(=O)O1)c1ccc(Cl)s1,1,10.1124/dmd.108.025569 10.1124/dmd.108.025551
Rivaroxaban,O=C(NC[C@H]1CN(c2ccc(N3CCOCC3=O)cc2)C(=O)O1)c1ccc(Cl)s1,M-6,O=C(NC[C@H]1CN(c2ccc(NCCO)cc2)C(=O)O1)c1ccc(Cl)s1,1,10.1124/dmd.108.025569 10.1124/dmd.108.025551
Rivaroxaban,O=C(NC[C@H]1CN(c2ccc(N3CCOCC3=O)cc2)C(=O)O1)c1ccc(Cl)s1,M-7,O=C(O)COCCNc1ccc(N2C[C@H](CNC(=O)c3ccc(Cl)s3)OC2=O)cc1,1,10.1124/dmd.108.025569 10.1124/dmd.108.025551
Rivaroxaban,O=C(NC[C@H]1CN(c2ccc(N3CCOCC3=O)cc2)C(=O)O1)c1ccc(Cl)s1,M-12,O=C(CNC(=O)c1ccc(Cl)s1)CNc1ccc(N2CCOCC2=O)cc1,1,10.1124/dmd.108.025569 10.1124/dmd.108.025551
Rivaroxaban,O=C(NC[C@H]1CN(c2ccc(N3CCOCC3=O)cc2)C(=O)O1)c1ccc(Cl)s1,M-13,O=C(O)c1ccc(Cl)s1,1,10.1124/dmd.108.025569 10.1124/dmd.108.025551
Rivaroxaban,O=C(NC[C@H]1CN(c2ccc(N3CCOCC3=O)cc2)C(=O)O1)c1ccc(Cl)s1,M-15,NC[C@H]1CN(c2ccc(N3CCOCC3=O)cc2)C(=O)O1,1,10.1124/dmd.108.025569 10.1124/dmd.108.025551
Rivaroxaban,O=C(NC[C@H]1CN(c2ccc(N3CCOCC3=O)cc2)C(=O)O1)c1ccc(Cl)s1,M-9,O=C(NC[C@@H]1OC(=O)N(c2ccc(N3CCOCC3=O)cc2)C1O)c1ccc(Cl)s1,1,10.1124/dmd.108.025569 10.1124/dmd.108.025551
Rivaroxaban,O=C(NC[C@H]1CN(c2ccc(N3CCOCC3=O)cc2)C(=O)O1)c1ccc(Cl)s1,M-8,O=C(NC[C@H]1CN(c2ccc(N3C(=O)COCC3O)cc2)C(=O)O1)c1ccc(Cl)s1,1,10.1124/dmd.108.025569 10.1124/dmd.108.025551
Rivaroxaban,O=C(NC[C@H]1CN(c2ccc(N3CCOCC3=O)cc2)C(=O)O1)c1ccc(Cl)s1,M-3,O=C(NC[C@H]1CN(c2ccc(N3CC(O)OCC3=O)cc2)C(=O)O1)c1ccc(Cl)s1,1,10.1124/dmd.108.025569 10.1124/dmd.108.025551
Ibrutinib,C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1,M26,Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)nn2[C@@H]1CCCN(C(=O)CCSCC(NC(=O)CCC(N)C(=O)O)C(=O)NCC(=O)O)C1,1,10.1124/dmd.114.060061
Ibrutinib,C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1,M37,Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)nn2[C@@H]1CCCN(C(=O)C(O)CO)C1,1,10.1124/dmd.114.060061
Cobicistat,CC(C)c1nc(CN(C)C(=O)N[C@@H](CCN2CCOCC2)C(=O)N[C@H](CC[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)Cc2ccccc2)cs1,M2,CC(C)c1nc(CN(C)C(=O)N[C@@H](CCN2CCOCC2)C(=O)N[C@H](CC[C@@H](N)Cc2ccccc2)Cc2ccccc2)cs1,1,10.2174/1872312810666160303112212
Cobicistat,CC(C)c1nc(CN(C)C(=O)N[C@@H](CCN2CCOCC2)C(=O)N[C@H](CC[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)Cc2ccccc2)cs1,M9,CNC(=O)N[C@@H](CCN1CCOCC1)C(=O)N[C@H](CC[C@H](Cc1ccccc1)NC(=O)OCc1cncs1)Cc1ccccc1,1,10.2174/1872312810666160303112212
Cobicistat,CC(C)c1nc(CN(C)C(=O)N[C@@H](CCN2CCOCC2)C(=O)N[C@H](CC[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)Cc2ccccc2)cs1,M3,CC(C)c1nc(CN(C)C(=O)N[C@@H](CCNCCO)C(=O)N[C@H](CC[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)Cc2ccccc2)cs1,1,10.2174/1872312810666160303112212
Sitagliptin,N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1cc(F)c(F)cc1F,M1,O=C(C[C@@H](Cc1cc(F)c(F)cc1F)NS(=O)(=O)O)N1CCn2c(nnc2C(F)(F)F)C1,1,10.1124/dmd.106.013136
Sitagliptin,N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1cc(F)c(F)cc1F,M4,O=C(N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1cc(F)c(F)cc1F)OC1OC(C(=O)O)C(O)C(O)C1O,1,10.1124/dmd.106.013136
Sitagliptin,N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1cc(F)c(F)cc1F,"M2,M5",O=C1CC(Cc2cc(F)c(F)cc2F)NC2c3nnc(C(F)(F)F)n3CCN12,1,10.1124/dmd.106.013136
Enzalutamide,CNC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C2(C)C)cc1F,carboxylic acid metabolite,CC1(C)C(=O)N(c2ccc(C#N)c(C(F)(F)F)c2)C(=S)N1c1ccc(C(=O)O)c(F)c1,1,10.1007/s40262-015-0271-5
Enzalutamide,CNC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C2(C)C)cc1F,N-desmethyl enzalutamide,CC1(C)C(=O)N(c2ccc(C#N)c(C(F)(F)F)c2)C(=S)N1c1ccc(C(N)=O)c(F)c1,1,10.1007/s40262-015-0271-5
Abacavir,Nc1nc(NC2CC2)c2ncn([C@H]3C=C[C@@H](CO)C3)c2n1,5'-carboxylate,Nc1nc(NC2CC2)c2ncn([C@H]3C=C[C@@H](C(=O)O)C3)c2n1,1,10.1016/s0009-2797(02)00059-5 PMID:10582871
Abacavir,Nc1nc(NC2CC2)c2ncn([C@H]3C=C[C@@H](CO)C3)c2n1,5'-glucuronide,Nc1nc(NC2CC2)c2ncn([C@H]3C=C[C@@H](COC4OC(C(=O)O)C(O)C(O)C4O)C3)c2n1,1,10.1016/s0009-2797(02)00059-5 PMID:10582871
Dolutegravir,C[C@@H]1CCO[C@H]2Cn3cc(C(=O)NCc4ccc(F)cc4F)c(=O)c(O)c3C(=O)N12,M2,C[C@@H]1CCO[C@H]2Cn3cc(C(=O)NCc4ccc(F)cc4F)c(=O)c(OC4OC(C(=O)O)C(O)C(O)C4O)c3C(=O)N12,1,10.1128/AAC.00292-13
Dolutegravir,C[C@@H]1CCO[C@H]2Cn3cc(C(=O)NCc4ccc(F)cc4F)c(=O)c(O)c3C(=O)N12,M3,C[C@@H]1CCO[C@H]2Cn3cc(C(=O)NC(O)c4ccc(F)cc4F)c(=O)c(O)c3C(=O)N12,1,10.1128/AAC.00292-13
Abiraterone,C[C@]12CC[C@H](O)CC1=CC[C@@H]1[C@@H]2CC[C@]2(C)C(c3cccnc3)=CC[C@@H]12,M75,C[C@]12CCC=CC1=CC[C@@H]1[C@@H]2CC[C@]2(C)C(c3cccnc3)=CC[C@@H]12,1,10.3109/00498254.2012.721022
Abiraterone,C[C@]12CC[C@H](O)CC1=CC[C@@H]1[C@@H]2CC[C@]2(C)C(c3cccnc3)=CC[C@@H]12,M45,C[C@]12CCC(OS(=O)(=O)O)CC1=CC[C@@H]1[C@@H]2CC[C@]2(C)C(c3cccnc3)=CC[C@@H]12,1,10.3109/00498254.2012.721022
Fingolimod,CCCCCCCCc1ccc(CCC(N)(CO)CO)cc1,M1,NC(CO)(CO)CCc1ccc(CCCCCCCC(=O)O)cc1,1,10.1124/dmd.110.035907
Fingolimod,CCCCCCCCc1ccc(CCC(N)(CO)CO)cc1,phosphate,CCCCCCCCc1ccc(CC[C@](N)(CO)COP(=O)(O)O)cc1,1,10.1124/dmd.110.035907
Fluticasone Propionate,CCC(=O)O[C@]1(C(=O)SCF)[C@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C,M1,CCC(=O)O[C@]1(C(=O)O)[C@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C,1,10.1152/ajplung.00108.2007 10.1124/dmd.105.009043
Budesonide,CCCC1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1,M-IV,CCC(O)C1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1,1,10.1007/s00216-012-6037-0
Budesonide,CCCC1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1,M-VI,CCCC1O[C@@H]2C[C@H]3[C@@H]4C=CC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1,1,10.1007/s00216-012-6037-0
Budesonide,CCCC1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1,M-II/M-III,CCCC1O[C@@H]2C[C@H]3[C@@H]4CC(O)C5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1,1,10.1007/s00216-012-6037-0
Budesonide,CCCC1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1,M-VII,CCCC1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4C(=O)C[C@]3(C)[C@]2(C(=O)CO)O1,1,10.1007/s00216-012-6037-0
Budesonide,CCCC1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1,M-VIII,CCCC1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(O)CO)O1,1,10.1007/s00216-012-6037-0
Budesonide,CCCC1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1,M-I,C[C@]12C=CC(=O)C=C1CC[C@@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1C[C@@H](O)[C@]2(O)C(=O)CO,1,10.1007/s00216-012-6037-0
Formoterol,COc1ccc(CC(C)NCC(O)c2ccc(O)c(NC=O)c2)cc1,Met 1,CC(Cc1ccc(O)cc1)NCC(O)c1ccc(O)c(NC=O)c1,1,PMID:10497135
Formoterol,COc1ccc(CC(C)NCC(O)c2ccc(O)c(NC=O)c2)cc1,FG1,COc1ccc(CC(C)NCC(O)c2ccc(OC3OC(C(=O)O)C(O)C(O)C3O)c(NC=O)c2)cc1,1,PMID:10497135
Formoterol,COc1ccc(CC(C)NCC(O)c2ccc(O)c(NC=O)c2)cc1,FG2,COc1ccc(CC(C)NCC(OC2OC(C(=O)O)C(O)C(O)C2O)c2ccc(O)c(NC=O)c2)cc1,1,PMID:10497135
Formoterol,COc1ccc(CC(C)NCC(O)c2ccc(O)c(NC=O)c2)cc1,FS,COc1ccc(CC(C)NCC(O)c2ccc(OS(=O)(=O)O)c(NC=O)c2)cc1,1,PMID:10497135
Esomeprazole,COc1ccc2[nH]c([S@@](=O)Cc3ncc(C)c(OC)c3C)nc2c1,5-O-desmethylomeprazole,COc1c(C)cnc(C[S@](=O)c2nc3cc(O)ccc3[nH]2)c1C,1,10.1021/acs.jpcb.8b01179 PMID:8331574
Esomeprazole,COc1ccc2[nH]c([S@@](=O)Cc3ncc(C)c(OC)c3C)nc2c1,omeprazole sulfone,COc1ccc2[nH]c(S(=O)(=O)Cc3ncc(C)c(OC)c3C)nc2c1,1,10.1021/acs.jpcb.8b01179 PMID:8331574
Empagliflozin,OC[C@H]1O[C@@H](c2ccc(Cl)c(Cc3ccc(O[C@H]4CCOC4)cc3)c2)[C@H](O)[C@@H](O)[C@@H]1O,M626/1,O=C(O)C1OC(O[C@@H]2[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]2c2ccc(Cl)c(Cc3ccc(O[C@H]4CCOC4)cc3)c2)C(O)C(O)C1O,1,10.3109/00498254.2014.999141
Empagliflozin,OC[C@H]1O[C@@H](c2ccc(Cl)c(Cc3ccc(O[C@H]4CCOC4)cc3)c2)[C@H](O)[C@@H](O)[C@@H]1O,M626/2,O=C(O)C1OC(OC[C@H]2O[C@@H](c3ccc(Cl)c(Cc4ccc(O[C@H]5CCOC5)cc4)c3)[C@H](O)[C@@H](O)[C@@H]2O)C(O)C(O)C1O,1,10.3109/00498254.2014.999141
Empagliflozin,OC[C@H]1O[C@@H](c2ccc(Cl)c(Cc3ccc(O[C@H]4CCOC4)cc3)c2)[C@H](O)[C@@H](O)[C@@H]1O,M626/3,O=C(O)C1OC(O[C@@H]2[C@@H](O)[C@H](c3ccc(Cl)c(Cc4ccc(O[C@H]5CCOC5)cc4)c3)O[C@H](CO)[C@H]2O)C(O)C(O)C1O,1,10.3109/00498254.2014.999141
Empagliflozin,OC[C@H]1O[C@@H](c2ccc(Cl)c(Cc3ccc(O[C@H]4CCOC4)cc3)c2)[C@H](O)[C@@H](O)[C@@H]1O,M468/1,OCC[C@@H](CO)Oc1ccc(Cc2cc([C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)ccc2Cl)cc1,1,10.3109/00498254.2014.999141
Dasatinib,Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1,M9,Cc1nc(Nc2ncc(C3=Nc4c(Cl)cccc4CO3)s2)cc(N2CCN(CCO)CC2)n1,1,10.1124/dmd.107.018267
Dasatinib,Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1,M6,Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CC(=O)O)CC2)n1,1,10.1124/dmd.107.018267
Dasatinib,Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1,M4,Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCNCC2)n1,1,10.1124/dmd.107.018267
Dasatinib,Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1,M20,Cc1nc(Nc2ncc(C(=O)Nc3c(C)cc(O)cc3Cl)s2)cc(N2CCN(CCO)CC2)n1,1,10.1124/dmd.107.018267
Dasatinib,Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1,M24,Cc1nc(Nc2ncc(C(=O)Nc3c(Cl)cccc3CO)s2)cc(N2CCN(CCO)CC2)n1,1,10.1124/dmd.107.018267
Dasatinib,Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1,M5,Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CC[N+]([O-])(CCO)CC2)n1,1,10.1124/dmd.107.018267
Atorvastatin,CC(C)c1c(C(=O)Nc2ccccc2)c(-c2ccccc2)c(-c2ccc(F)cc2)n1CC[C@@H](O)C[C@@H](O)CC(=O)O,para-hydroxyatorvastatin,CC(C)c1c(C(=O)Nc2ccc(O)cc2)c(-c2ccccc2)c(-c2ccc(F)cc2)n1CC[C@@H](O)C[C@@H](O)CC(=O)O,1,10.1080/00498250802334391
Atorvastatin,CC(C)c1c(C(=O)Nc2ccccc2)c(-c2ccccc2)c(-c2ccc(F)cc2)n1CC[C@@H](O)C[C@@H](O)CC(=O)O,ortho-hydroxyatorvastatin,CC(C)c1c(C(=O)Nc2ccccc2O)c(-c2ccccc2)c(-c2ccc(F)cc2)n1CC[C@@H](O)C[C@@H](O)CC(=O)O,1,10.1080/00498250802334391
Pomalidomide,Nc1cccc2c1C(=O)N(C1CCC(=O)NC1=O)C2=O,M10,NC(=O)C(CCC(=O)O)N1C(=O)c2cccc(N)c2C1=O,1,10.1007/s00280-012-2040-6
Pomalidomide,Nc1cccc2c1C(=O)N(C1CCC(=O)NC1=O)C2=O,M16,Nc1ccc(O)c2c1C(=O)N(C1CCC(=O)NC1=O)C2=O,1,10.1007/s00280-012-2040-6
Pomalidomide,Nc1cccc2c1C(=O)N(C1CCC(=O)NC1=O)C2=O,M12,Nc1cccc(C(=O)O)c1C(=O)O,1,10.1007/s00280-012-2040-6
Pomalidomide,Nc1cccc2c1C(=O)N(C1CCC(=O)NC1=O)C2=O,M19,Nc1cccc2c1C(=O)N(C1CC(O)C(=O)NC1=O)C2=O,1,10.1007/s00280-012-2040-6
Pomalidomide,Nc1cccc2c1C(=O)N(C1CCC(=O)NC1=O)C2=O,M11,NC(=O)CCC(C(=O)O)N1C(=O)c2cccc(N)c2C1=O,1,10.1007/s00280-012-2040-6
Pomalidomide,Nc1cccc2c1C(=O)N(C1CCC(=O)NC1=O)C2=O,M18,O=C(O)Nc1cccc2c1C(=O)N(C1CCC(=O)NC1=O)C2=O,1,10.1007/s00280-012-2040-6
Pomalidomide,Nc1cccc2c1C(=O)N(C1CCC(=O)NC1=O)C2=O,M17,Nc1c(O)ccc2c1C(=O)N(C1CCC(=O)NC1=O)C2=O,1,10.1007/s00280-012-2040-6
Sofosbuvir,CC(C)OC(=O)[C@H](C)N[P@](=O)(OC[C@H]1O[C@@H](n2ccc(=O)[nH]c2=O)[C@](C)(F)[C@@H]1O)Oc1ccccc1,first metabolite,C[C@H](N[P@](=O)(OC[C@H]1O[C@@H](n2ccc(=O)[nH]c2=O)[C@](C)(F)[C@@H]1O)Oc1ccccc1)C(=O)O,1,10.1074/jbc.M110.161802
Darunavir,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@H]21)S(=O)(=O)c1ccc(N)cc1,M23,CC(C)(O)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@H]21)S(=O)(=O)c1ccc(N)cc1,1,10.1124/dmd.108.024109
Darunavir,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@H]21)S(=O)(=O)c1ccc(N)cc1,M19,CC(C)CN(C[C@@H](O)[C@@H](N)Cc1ccccc1)S(=O)(=O)c1ccc(N)cc1,1,10.1124/dmd.108.024109
Darunavir,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@H]21)S(=O)(=O)c1ccc(N)cc1,M33,CC(C)CN(C[C@@H](O)[C@H](Cc1ccc(O)cc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@H]21)S(=O)(=O)c1ccc(N)cc1,1,10.1124/dmd.108.024109
Darunavir,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@H]21)S(=O)(=O)c1ccc(N)cc1,M20,CC(C)CN(C[C@@H](OC1OC(C(=O)O)C(O)C(O)C1O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@H]21)S(=O)(=O)c1ccc(N)cc1,1,10.1124/dmd.108.024109
Darunavir,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@H]21)S(=O)(=O)c1ccc(N)cc1,M18,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@H]21)S(=O)(=O)c1ccc(NC2OC(C(=O)O)C(O)C(O)C2O)cc1,1,10.1124/dmd.108.024109
Darunavir,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@H]21)S(=O)(=O)c1ccc(N)cc1,M29,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@H]21)S(=O)(=O)c1ccc(N)c(O)c1,1,10.1124/dmd.108.024109
Nilotinib ,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,P42.1,Cc1cn(-c2cc(NC(=O)c3ccc(CO)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,1,10.1182/blood.V122.21.4011.4011
Nilotinib ,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,P41.6,Cc1ccc(C(=O)Nc2cc(-n3cnc(CO)c3)cc(C(F)(F)F)c2)cc1Nc1nccc(-c2cccnc2)n1,1,10.1182/blood.V122.21.4011.4011
Nilotinib ,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,P36.5,Cc1ccc(C(=O)Nc2cc(-n3cnc(C(=O)O)c3)cc(C(F)(F)F)c2)cc1Nc1nccc(-c2cccnc2)n1,1,10.1182/blood.V122.21.4011.4011
Nilotinib ,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,P36,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5ccc[n+]([O-])c5)n4)c3)cc(C(F)(F)F)c2)cn1,1,10.1182/blood.V122.21.4011.4011
Nilotinib ,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,P50,Cc1ccc(C(=O)Nc2cc(N)cc(C(F)(F)F)c2)cc1Nc1nccc(-c2cccnc2)n1,1,10.1182/blood.V122.21.4011.4011
Osimertinib,C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C,AZ5104,C=CC(=O)Nc1cc(Nc2nccc(-c3c[nH]c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C,1,10.1124/dmd.115.069203
Osimertinib,C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C,AZ7550,C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCNC,1,10.1124/dmd.115.069203
Osimertinib,C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C,M1,C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CC[N+](C)(C)[O-],1,10.1124/dmd.115.069203
Osimertinib,C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C,M8,COc1cc(N(C)CCN(C)C)c(NC(=O)CCSCC(N)C(=O)NCC(=O)O)cc1Nc1nccc(-c2cn(C)c3ccccc23)n1,1,10.1124/dmd.115.069203
Osimertinib,C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C,M2,C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1NC,1,10.1124/dmd.115.069203
Osimertinib,C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C,M21,COc1cc(N(C)CCN(C)C)c(NC(=O)CCSCC(N)C(=O)O)cc1Nc1nccc(-c2cn(C)c3ccccc23)n1,1,10.1124/dmd.115.069203
Osimertinib,C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C,M10,COc1cc(N(C)CCN(C)C)c(NC(=O)CCSCC(NC(=O)CCC(N)C(=O)O)C(=O)NCC(=O)O)cc1Nc1nccc(-c2cn(C)c3ccccc23)n1,1,10.1124/dmd.115.069203
Tacrolimus,C=CC[C@@H]1/C=C(\C)C[C@H](C)C[C@H](OC)[C@H]2O[C@@](O)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@H](/C(C)=C/[C@@H]3CC[C@@H](O)[C@H](OC)C3)[C@H](C)[C@@H](O)CC1=O)[C@H](C)C[C@@H]2OC,M-I,C=CC[C@@H]1/C=C(\C)C[C@H](C)C[C@H](OC)C(O)C2C[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H](/C(C)=C/[C@@H]2CC[C@@H](O)[C@H](OC)C2)[C@H](C)[C@@H](O)CC1=O,1,10.2133/dmpk.22.328
Cinacalcet,C[C@@H](NCCCc1cccc(C(F)(F)F)c1)c1cccc2ccccc12,M2a-Glu,C[C@@H](NCCCc1cccc(C(F)(F)F)c1)C1=C[C@@H](O)[C@H](OC2OC(C(=O)O)C(O)C(O)C2O)c2ccccc21,1,10.1124/dmd.104.000604
Cinacalcet,C[C@@H](NCCCc1cccc(C(F)(F)F)c1)c1cccc2ccccc12,M5,O=C(O)CCc1cccc(C(F)(F)F)c1,1,10.1124/dmd.104.000604
Tofacitinib,C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12,M1,C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1Nc1ncnc2[nH]ccc12,1,10.1124/dmd.113.054940
Tofacitinib,C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12,M2,C[C@@H]1CCN(C(=O)CO)C[C@@H]1N(C)c1ncnc2[nH]ccc12,1,10.1124/dmd.113.054940
Tofacitinib,C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12,M4,C[C@@H]1CCN(C(=O)C(=O)O)C[C@@H]1N(C)c1ncnc2[nH]ccc12,1,10.1124/dmd.113.054940
Tofacitinib,C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12,M9,C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1Nc1ncnc2c1CC(=O)N2,1,10.1124/dmd.113.054940
Dabigatran,Cn1c(CNc2ccc(C(=N)N)cc2)nc2cc(C(=O)N(CCC(=O)O)c3ccccn3)ccc21,M400,Cn1c(CNc2ccc(C(=N)N)cc2)nc2cc(C(=O)Nc3ccccn3)ccc21,1,10.1124/dmd.107.019083
Dabigatran,Cn1c(CNc2ccc(C(=N)N)cc2)nc2cc(C(=O)N(CCC(=O)O)c3ccccn3)ccc21,M369,Cn1c(C(=O)O)nc2cc(C(=O)N(CCC(=O)O)c3ccccn3)ccc21,1,10.1124/dmd.107.019083
Dabigatran,Cn1c(CNc2ccc(C(=N)N)cc2)nc2cc(C(=O)N(CCC(=O)O)c3ccccn3)ccc21,M324,Cn1c(CNc2ccc(C(=N)N)cc2)nc2cc(C(=O)O)ccc21,1,10.1124/dmd.107.019083
Dabigatran,Cn1c(CNc2ccc(C(=N)N)cc2)nc2cc(C(=O)N(CCC(=O)O)c3ccccn3)ccc21,M355,Cn1c(CO)nc2cc(C(=O)N(CCC(=O)O)c3ccccn3)ccc21,1,10.1124/dmd.107.019083
Dabigatran,Cn1c(CNc2ccc(C(=N)N)cc2)nc2cc(C(=O)N(CCC(=O)O)c3ccccn3)ccc21,M648,Cn1c(CNc2ccc(C(=N)N)cc2)nc2cc(C(=O)N(CCC(=O)OC3CC(C(=O)O)C(O)C(O)C3O)c3ccccn3)ccc21,1,10.1124/dmd.107.019083
Lurasidone,O=C1[C@@H]2[C@H]3CC[C@H](C3)[C@@H]2C(=O)N1C[C@@H]1CCCC[C@H]1CN1CCN(c2nsc3ccccc23)CC1,BITP,c1ccc2c(N3CCNCC3)nsc2c1,1,10.2147/NDT.S18059
Clopidogrel,COC(=O)[C@H](c1ccccc1Cl)N1CCc2sccc2C1,clopidogrel-carboxylic acid,O=C(O)[C@H](c1ccccc1Cl)N1CCc2sccc2C1,1,10.1124/jpet.112.201640
Clopidogrel,COC(=O)[C@H](c1ccccc1Cl)N1CCc2sccc2C1,2-oxo-clopidogrel,COC(=O)[C@H](c1ccccc1Cl)N1CCC2SC(=O)C=C2C1,1,10.1124/jpet.112.201640
Apremilast,CCOc1cc([C@@H](CS(C)(=O)=O)N2C(=O)c3cccc(NC(C)=O)c3C2=O)ccc1OC,M1/M2,CCOc1cc([C@@H](CS(C)(=O)=O)NC(=O)c2cccc(NC(C)=O)c2C(=O)O)ccc1OC,1,10.3109/00498254.2011.604745
Apremilast,CCOc1cc([C@@H](CS(C)(=O)=O)N2C(=O)c3cccc(NC(C)=O)c3C2=O)ccc1OC,M3,CCOc1cc([C@@H](CS(C)(=O)=O)N2C(=O)c3cccc(NC(C)=O)c3C2=O)ccc1O,1,10.3109/00498254.2011.604745
Apremilast,CCOc1cc([C@@H](CS(C)(=O)=O)N2C(=O)c3cccc(NC(C)=O)c3C2=O)ccc1OC,M19,CC(=O)Nc1cccc2c1C(=O)N([C@H](CS(C)(=O)=O)c1ccc(O)c(O)c1)C2=O,1,10.3109/00498254.2011.604745
Apremilast,CCOc1cc([C@@H](CS(C)(=O)=O)N2C(=O)c3cccc(NC(C)=O)c3C2=O)ccc1OC,M22,COc1ccc([C@@H](CS(C)(=O)=O)N2C(=O)c3cccc(NC(C)=O)c3C2=O)cc1O,1,10.3109/00498254.2011.604745
Apremilast,CCOc1cc([C@@H](CS(C)(=O)=O)N2C(=O)c3cccc(NC(C)=O)c3C2=O)ccc1OC,M13,COc1ccc([C@@H](CS(C)(=O)=O)N2C(=O)c3cccc(NC(C)=O)c3C2=O)cc1OC1OC(C(=O)O)C(O)C(O)C1O,1,10.3109/00498254.2011.604745
Apremilast,CCOc1cc([C@@H](CS(C)(=O)=O)N2C(=O)c3cccc(NC(C)=O)c3C2=O)ccc1OC,M7,CCOc1cc([C@@H](CS(C)(=O)=O)N2C(=O)c3cccc(N)c3C2=O)ccc1OC,1,10.3109/00498254.2011.604745
Apremilast,CCOc1cc([C@@H](CS(C)(=O)=O)N2C(=O)c3cccc(NC(C)=O)c3C2=O)ccc1OC,M17,CCOc1cc([C@@H](CS(C)(=O)=O)N2C(=O)c3cccc(NC(=O)CO)c3C2=O)ccc1OC,1,10.3109/00498254.2011.604745
Rilpivirine,Cc1cc(/C=C/C#N)cc(C)c1Nc1ccnc(Nc2ccc(C#N)cc2)n1,M2,Cc1cc(/C=C/C#N)cc(CO)c1Nc1ccnc(Nc2ccc(C#N)cc2)n1,1,10.1128/AAC.01401-13
Rilpivirine,Cc1cc(/C=C/C#N)cc(C)c1Nc1ccnc(Nc2ccc(C#N)cc2)n1,M4,N#C/C=C/c1cc(CO)c(Nc2ccnc(Nc3ccc(C#N)cc3)n2)c(CO)c1,1,10.1128/AAC.01401-13
Rilpivirine,Cc1cc(/C=C/C#N)cc(C)c1Nc1ccnc(Nc2ccc(C#N)cc2)n1,M5,Cc1cc(/C=C/C#N)cc(C)c1NC1C=CN(C2OC(C(=O)O)C(O)C(O)C2O)C(Nc2ccc(C#N)cc2)=N1,1,10.1128/AAC.01401-13
Linagliptin,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(Cc1nc(C)c3ccccc3n1)c(=O)n2C,M515,CC#CCn1c(N2CCC[C@@H](NC(C)=O)C2)nc2c1c(=O)n(Cc1nc(C)c3ccccc3n1)c(=O)n2C,1,10.1124/dmd.109.031476
Linagliptin,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(Cc1nc(C)c3ccccc3n1)c(=O)n2C,M489,Cc1nc(Cn2c(=O)c3c(nc(N4CCC[C@@H](N)C4)n3CC#CCO)n(C)c2=O)nc2ccccc12,1,10.1124/dmd.109.031476
Linagliptin,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(Cc1nc(C)c3ccccc3n1)c(=O)n2C,CD10604,CC#CCn1c(N2CCCC(=O)C2)nc2c1c(=O)n(Cc1nc(C)c3ccccc3n1)c(=O)n2C,1,10.1124/dmd.109.031476
Linagliptin,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(Cc1nc(C)c3ccccc3n1)c(=O)n2C,M503,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(Cc1nc(C(=O)O)c3ccccc3n1)c(=O)n2C,1,10.1124/dmd.109.031476
Imatinib,Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1,CGP74588,Cc1ccc(NC(=O)c2ccc(CN3CCNCC3)cc2)cc1Nc1nccc(-c2cccnc2)n1,1,10.1124/dmd.105.004283
Imatinib,Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1,CGP72383,Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2ccc[n+]([O-])c2)n1,1,10.1124/dmd.105.004283
Imatinib,Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1,AFN911,CN1CCN(Cc2ccc(C(=O)Nc3ccc(CO)c(Nc4nccc(-c5cccnc5)n4)c3)cc2)CC1,1,10.1124/dmd.105.004283
Imatinib,Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1,CGP71422,Cc1ccc(NC(=O)c2ccc(CN3CC[N+](C)([O-])CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1,1,10.1124/dmd.105.004283
Imatinib,Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1,AGP050,Cc1ccc(NC(=O)c2ccc(CN3CCN(C)C(=O)C3)cc2)cc1Nc1nccc(-c2cccnc2)n1,1,10.1124/dmd.105.004283
Imatinib,Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1,M29.6,Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3=O)cc2)cc1Nc1nccc(-c2cccnc2)n1,1,10.1124/dmd.105.004283
Imatinib,Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1,M42.2,Cc1ccc(NC(=O)c2ccc(C(=O)O)cc2)cc1Nc1nccc(-c2cccnc2)n1,1,10.1124/dmd.105.004283
Everolimus,CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C,16-O-des,CO[C@@H]1C[C@H](C[C@@H](C)[C@@H]2CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C(\C)[C@@H](O)C[C@@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N3CCCC[C@H]3C(=O)O2)CC[C@H]1OCCO,1,10.1016/S0041-1345(00)02116-3 10.1124/dmd.108.020651
Everolimus,CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C,27-O-des,CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](O)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C,1,10.1016/S0041-1345(00)02116-3 10.1124/dmd.108.020651
Everolimus,CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C,39-O-des,CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](O)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C,1,10.1016/S0041-1345(00)02116-3 10.1124/dmd.108.020651
Everolimus,CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C,11-OH,CO[C@H]1C[C@@H]2CC[C@](C)(O)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C,1,10.1016/S0041-1345(00)02116-3 10.1124/dmd.108.020651
Everolimus,CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C,12-OH,CO[C@H]1C[C@@H]2CC(O)[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C,1,10.1016/S0041-1345(00)02116-3 10.1124/dmd.108.020651
Everolimus,CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C,14-OH,CO[C@H]1C[C@@]2(O)CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C,1,10.1016/S0041-1345(00)02116-3 10.1124/dmd.108.020651
Everolimus,CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C,24-OH,CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C(O)[C@H](C)/C=C/C=C/C=C/1C,1,10.1016/S0041-1345(00)02116-3 10.1124/dmd.108.020651
Everolimus,CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C,25-OH,CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@](C)(O)C[C@H](C)/C=C/C=C/C=C/1C,1,10.1016/S0041-1345(00)02116-3 10.1124/dmd.108.020651
Everolimus,CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C,46-OH,CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](CO)C[C@H](C)/C=C/C=C/C=C/1C,1,10.1016/S0041-1345(00)02116-3 10.1124/dmd.108.020651
Everolimus,CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C,49-OH,CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](CO)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C,1,10.1016/S0041-1345(00)02116-3 10.1124/dmd.108.020651
Everolimus,CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C,rapamycin,CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C,1,10.1016/S0041-1345(00)02116-3 10.1124/dmd.108.020651
Everolimus,CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C,ATG181,CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCOP(=O)(O)OCC[N+](C)(C)C)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C,1,10.1016/S0041-1345(00)02116-3 10.1124/dmd.108.020651
Rosuvastatin,CC(C)c1nc(N(C)S(C)(=O)=O)nc(-c2ccc(F)cc2)c1/C=C/[C@@H](O)C[C@@H](O)CC(=O)O,N-desmethyl rosuvastatin,CC(C)c1nc(NS(C)(=O)=O)nc(-c2ccc(F)cc2)c1/C=C/[C@@H](O)C[C@@H](O)CC(=O)O,1,10.1016/s0149-2918(03)80336-3
Rosuvastatin,CC(C)c1nc(N(C)S(C)(=O)=O)nc(-c2ccc(F)cc2)c1/C=C/[C@@H](O)C[C@@H](O)CC(=O)O,rosuvastatin-5S-lactone,CC(C)c1nc(N(C)S(C)(=O)=O)nc(-c2ccc(F)cc2)c1/C=C/[C@@]1(O)C[C@@H](O)CC(=O)O1,1,10.1016/s0149-2918(03)80336-3
Dapagliflozin,CCOc1ccc(Cc2cc([C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)ccc2Cl)cc1,M8,OC[C@H]1O[C@@H](c2ccc(Cl)c(Cc3ccc(O)cc3)c2)[C@H](O)[C@@H](O)[C@@H]1O,1,10.1124/dmd.109.029165
Dapagliflozin,CCOc1ccc(Cc2cc([C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)ccc2Cl)cc1,M12,CCOc1ccc(C(O)c2cc([C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)ccc2Cl)cc1,1,10.1124/dmd.109.029165
Ticagrelor,CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@@H]3C[C@H](OCCO)[C@@H](O)[C@H]3O)c2n1,M5,CCCSc1nc(N)c2nnn([C@@H]3C[C@H](OCCO)[C@@H](O)[C@H]3O)c2n1,1,10.1124/dmd.110.032250
Ticagrelor,CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@@H]3C[C@H](OCCO)[C@@H](O)[C@H]3O)c2n1,M8,CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@@H]3C[C@H](O)[C@@H](O)[C@H]3O)c2n1,1,10.1124/dmd.110.032250
